the FDA
-
Upload
amy-daugherty -
Category
Documents
-
view
27 -
download
2
description
Transcript of the FDA
![Page 1: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/1.jpg)
the
FDAFDAGatmaitan – Medrano
![Page 2: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/2.jpg)
Food and Drug Administration
• Formerly the Bureau of Food and Drugs (BFAD)
• Has several functions and powers acting as a regulatory board for all food and drugs marketed.
• It was reorganized under the Republic Act 9711.
![Page 3: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/3.jpg)
The Functions of the FDA… Can be classified into 4 major groups:
The collection and quality, efficacy and SAFETY testing of health products samples.
Collection of data on adverse events and possibly harmful products (largely reactionary)
The recommendation of standards in the storage, distribution and manufacture of drugs.
The conduction of research on food and drug products.
![Page 4: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/4.jpg)
So…
![Page 5: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/5.jpg)
Specific provisionso To administer the effective
implementation of R.A. 9711 and of the rules and regulations issued pursuant to the same;
o To assume primary jurisdiction in the collection of samples of health products;
o To analyze and inspect health products in connection with the implementation of R.A. 9711;
o To establish analytical data to serve as basis for the preparation of health products standards, and to recommend standards of identity, purity, safety, efficacy, quality and fill of container;
![Page 6: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/6.jpg)
Specific provisionso To conduct appropriate tests on all
applicable health products prior to the issuance of appropriate authorizations to ensure safety, efficacy, purity, and quality;
o To require all manufacturers, traders, distributors, importers, exporters, wholesalers, retailers, consumers, and non-consumer users of health products to report to the FDA any incident that reasonably indicates that said product has caused or contributed to the death, serious illness or serious injury to a consumer, a patient, or any person;
![Page 7: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/7.jpg)
Specific provisionso To issue cease and desist orders motu
propio or upon verified complaint for health produts, whether or not registered with the FDA Provided,
o After due process, to order the ban, recall, and/or withdrawal of any health product found to have caused the death, serious illness or serious injury to a consumer or patient, or is found to be imminently injurious, unsafe, dangerous, or grossly deceptive, and to require all concerned to implement the risk management plan which is a requirement for the issuance of the appropriate authorization;
![Page 8: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/8.jpg)
Specific provisionso To strengthen the post market
surveillance system in monitoring health products as defined in R.A. 9711 and incidents of adverse events involving such products;
o To develop and issue standards and appropriate authorizations that would cover establishments, facilities and health products;
o To conduct, supervise, monitor and audit research studies on health and safety issues of health products undertaken by entities duly approved by the FDA;
![Page 9: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/9.jpg)
Specific provisionso To prescribe standards, guidelines,
and regulations with respect to information, advertisements and other marketing instruments and promotion, sponsorship, and other marketing activities about the health products as covered in R.A. 9711;
o To maintain bonded warehouses and/or establish the same, whenever necessary or appropriate, as determined by the director-general for confiscated goods in strategic areas of the country especially at major ports of entry; and
o To exercise such other powers and perform such other functions that may be necessary to carry out its duties and responsibilities under R.A.9711.
![Page 10: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/10.jpg)
![Page 11: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/11.jpg)
![Page 12: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/12.jpg)
A food/dietary supplement…
Is a processed food product intended to supplement the diet
![Page 13: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/13.jpg)
A food/dietary supplement…
conforms to the latest Philippine recommended energy
and nutrient intakes or internationally agreed minimum
daily requirements.
![Page 14: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/14.jpg)
Herbal medicines are…
finished, labeled, medicinal products that contain as active
ingredient/s aerial or underground part/s of plant or other materials or combination thereof, whether in the crude state or as plant preparations.
![Page 15: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/15.jpg)
Herbal medicines are…
![Page 16: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/16.jpg)
Herbal medicines are… recognized in the Philippine National
Formulary; intended for use in the treatment or
cure, mitigation, of disease symptoms, injury or bodily defect for use in man;
other than food, intended to affect the structure of any function of the body of man;
put into finishes, ready to use form by means of formulation, dosage or dosage directions;
![Page 17: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/17.jpg)
![Page 18: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/18.jpg)
![Page 19: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/19.jpg)
How are locally manufactured drugs approved?
![Page 20: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/20.jpg)
Step 1: Application (A.O. 42)
The application contains all the following:Full list and amount of all ingredients used Technical specification of all the ingredients used as component.Description of the finished drug product.Labels, labelling materials, package insert, brochures and other advertising materialsSufficient sample for laboratory analysis.
![Page 21: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/21.jpg)
Step 2: Safety Tests Oral LD50 in Rats Pharmacologic studies
in vitro-depending on tissue uses; on dogs, cats and turtles
in vivo-on-dogs and cats. Mutagenicity studies
in vitro in vivo
Date on safety and efficacy Dosage formulation
![Page 22: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/22.jpg)
Step 3: Quality Control Test for the presence of synthetic drugs Test for the presence of heavy metals Test for alcohol content (<10%) Analysis for Impurities Characteristics of the drug in tablet
form, suspension form, ointment and suppository preparations.
![Page 23: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/23.jpg)
Step 4: Payment Drug preparation containing only one
active ingredient shall be charged a fee of fifty pesos (P50.00)
Those containing more than one active ingredients shall be charged a fee of one hundred pesos (P100.00)
![Page 24: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/24.jpg)
Administrative Acts of the FDAEO 51 – Milk CodeIRR of EO 51 - Revised
Implementing Rules & Regulations of Milk Code
EO 302 – Philippine PharmacopoeiaRA 9257 - Expanded Senior Citizens
Act of 2003RA 9211 – Tobacco regulation Act of
2003IRR of RA 9211 – Inter-Agency
Committee - Tobacco
![Page 25: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/25.jpg)
![Page 26: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/26.jpg)
![Page 27: the FDA](https://reader035.fdocuments.in/reader035/viewer/2022062517/56812d50550346895d925223/html5/thumbnails/27.jpg)
Rationale of Renaming BFAD
RA No. 9711 The Bureau of Food and Drugs (BFAD) was renamed as the Food and Drug Administration (FDA) to strengthen and rationalize its regulatory capacity thru
The establishment of adequate testing laboratories and field offices,
Upgrading its equipment Augmenting its human resource
complement And by giving authority to retain its
income